Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Coherus Bio (NQ: CHRS )

4.239 -0.111 (-2.54%)
Streaming Delayed Price Updated: 11:05 AM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 603,042
Open 4.350
Bid (Size) 4.230 (4)
Ask (Size) 4.240 (11)
Prev. Close 4.350
Today's Range 4.130 - 4.415
52wk Range 4.160 - 14.03
Shares Outstanding 80,553,730
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 5 Health Care Stocks That Could Blast Off In May
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Looking Into Coherus BioSciences's Return On Capital Employed
 
Via Benzinga

Performance

YTD
-50.18%
-50.18%
1 Month
-44.73%
-44.73%
3 Month
-39.35%
-39.35%
6 Month
-34.17%
-34.17%
1 Year
-42.24%
-42.24%

More News

Read More
6 Analysts Have This to Say About Coherus BioSciences
Via Benzinga
Coherus Announces U.S. Launch of UDENYCA® Autoinjector
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus Prices Public Offering of Common Stock
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus BioSciences Earnings Preview
Via Benzinga
Coherus BioSciences's Return On Capital Employed Overview
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Vodafone, Calliditas Therapeutics, Rumble And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Coherus Announces Proposed Public Offering of Common Stock
From Coherus BioSciences, Inc.
Via GlobeNewswire
Gold Edges Higher; PayPal Shares Tumble Despite Upbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus BioSciences to Present at Upcoming Investor Conferences in May
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus BioSciences to Report First Quarter 2023 Financial Results on May 8, 2023
From Coherus BioSciences, Inc.
Via GlobeNewswire
Analyst Sees A Multibagger, Initiates Coverage On This 'Top Notch Biosimilar Business'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
Via Benzinga
Coherus and Junshi Biosciences Announce Toripalimab Studies to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
From Coherus BioSciences, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
Via Benzinga
PVH, First Republic Bank And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Via Benzinga
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
From Coherus BioSciences, Inc.
Via GlobeNewswire
FDA Approves UDENYCA® Autoinjector
From Coherus BioSciences, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.